XML 45 R26.htm IDEA: XBRL DOCUMENT v3.20.2

Business Segments (Tables)

9 Months Ended

Sep. 30, 2020

Business Segments

Schedule of business segmentation

Three months ended		Consumer								Analytical Reference
September 30, 2020		Products				Ingredients				Standards and				Corporate
(In thousands)		segment				segment				Services segment				and other				Total
Net sales		$	11,904			$	1,510			$	766			$	-			$	14,180
Cost of sales			4,404				599				723				-				5,726
Gross profit			7,500				911				43				-				8,454
Operating expenses:
Sales and marketing			5,018				47				158				-				5,223
Research and development			819				61				-				-				880
General and administrative			-				-				-				6,547				6,547
Operating expenses			5,837				108				158				6,547				12,650
Operating income (loss)		$	1,663			$	803			$	(115	)		$	(6,547	)		$	(4,196	)

Three months ended		Consumer								Analytical Reference
September 30, 2019		Products				Ingredients				Standards and				Corporate
(In thousands)		segment				segment				Services segment				and other				Total
Net sales		$	9,725			$	1,239			$	1,089			$	-			$	12,053
Cost of sales			3,901				614				789				-				5,304
Gross profit			5,824				625				300				-				6,749
Operating expenses:
Sales and marketing			4,451				45				130				-				4,626
Research and development			910				134				-				-				1,044
General and administrative			-				-				-				7,967				7,967
Other			-				-				-				-				-
Operating expenses			5,361				179				130				7,967				13,637
Operating income (loss)		$	463			$	446			$	170			$	(7,967	)		$	(6,888	)

Nine months ended		Consumer								Analytical Reference
September 30, 2020		Products				Ingredients				Standards and				Corporate
(In thousands)		segment				segment				Services segment				and other				Total
Net sales		$	34,768			$	6,835			$	2,209			$	-			$	43,812
Cost of sales			13,045				2,790				2,124				-				17,959
Gross profit			21,723				4,045				85				-				25,853
Operating expenses:
Sales and marketing			14,170				39				420				-				14,629
Research and development			2,406				335				-				-				2,741
General and administrative			-				-				-				22,256				22,256
Operating expenses			16,576				374				420				22,256				39,626
Operating income (loss)		$	5,147			$	3,671			$	(335	)		$	(22,256	)		$	(13,773	)

Nine months ended		Consumer								Analytical Reference
September 30, 2019		Products				Ingredients				Standards and				Corporate
(In thousands)		segment				segment				Services segment				and other				Total
Net sales		$	25,923			$	4,120			$	3,159			$	-			$	33,202
Cost of sales			10,491				2,068				2,339				-				14,898
Gross profit			15,432				2,052				820				-				18,304
Operating expenses:
Sales and marketing			12,440				236				432				-				13,108
Research and development			2,754				527				-				-				3,281
General and administrative			-				-				-				24,230				24,230
Other			-				-				-				125				125
Operating expenses			15,194				763				432				24,355				40,744
Operating income (loss)		$	238			$	1,289			$	388			$	(24,355	)		$	(22,440	)

		Consumer								Analytical Reference
At September 30, 2020		Products				Ingredients				Standards and				Corporate
(In thousands)		segment				segment				Services segment				and other				Total
Total assets		$	12,956			$	2,036			$	928			$	21,495			$	37,415

		Consumer								Analytical Reference
At December 31, 2019		Products				Ingredients				Standards and				Corporate
(In thousands)		segment				segment				Services segment				and other				Total
Total assets		$	12,137			$	2,135			$	918			$	25,057			$	40,247

Schedule of disaggregation of revenue

Three Months Ended September 30, 2020 (In thousands)		Consumer Products Segment				Ingredients Segment				Analytical Reference Standards and Services Segment				Total
TRU NIAGEN®, Consumer Product		$	11,904			$	-			$	-			$	11,904
NIAGEN® Ingredient			-				879				-				879
Subtotal NIAGEN Related		$	11,904			$	879			$	-			$	12,783
Other Ingredients			-				631				-				631
Reference Standards			-				-				695				695
Consulting and Other			-				-				71				71
Subtotal Other Goods and Services		$	-			$	631			$	766			$	1,397
Total Net Sales		$	11,904			$	1,510			$	766			$	14,180

Three Months Ended September 30, 2019 (In thousands)		Consumer Products Segment				Ingredients Segment				Analytical Reference Standards and Services Segment				Total
TRU NIAGEN®, Consumer Product		$	9,725			$	-			$	-			$	9,725
NIAGEN® Ingredient			-				731				-				731
Subtotal NIAGEN Related		$	9,725			$	731			$	-			$	10,456
Other Ingredients			-				508				-				508
Reference Standards			-				-				764				764
Consulting and Other			-				-				325				325
Subtotal Other Goods and Services		$	-			$	508			$	1,089			$	1,597
Total Net Sales		$	9,725			$	1,239			$	1,089			$	12,053

Nine Months Ended September 30, 2020 (In thousands)		Consumer Products Segment				Ingredients Segment				Analytical Reference Standards and Services Segment				Total
TRU NIAGEN®, Consumer Product		$	34,768			$	-			$	-			$	34,768
NIAGEN® Ingredient			-				4,835				-				4,835
Subtotal NIAGEN Related		$	34,768			$	4,835			$	-			$	39,603
Other Ingredients			-				2,000				-				2,000
Reference Standards			-				-				2,054				2,054
Consulting and Other			-				-				155				155
Subtotal Other Goods and Services		$	-			$	2,000			$	2,209			$	4,209
Total Net Sales		$	34,768			$	6,835			$	2,209			$	43,812

Nine Months Ended September 30, 2019 (In thousands)		Consumer Products Segment				Ingredients Segment				Analytical Reference Standards and Services Segment				Total
TRU NIAGEN®, Consumer Product		$	25,923			$	-			$	-			$	25,923
NIAGEN® Ingredient			-				2,921				-				2,921
Subtotal NIAGEN Related		$	25,923			$	2,921			$	-			$	28,844
Other Ingredients			-				1,199				-				1,199
Reference Standards			-				-				2,311				2,311
Consulting and Other			-				-				848				848
Subtotal Other Goods and Services		$	-			$	1,199			$	3,159			$	4,358
Total Net Sales		$	25,923			$	4,120			$	3,159			$	33,202

Schedule of disclosure of major customers

		Three months ended								Nine months ended
Major Customers		Sep. 30, 2020				Sep. 30, 2019				Sep. 30, 2020				Sep. 30, 2019
A.S. Watson Group - Related Party			17.7	%			18.8	%			12.9	%			16.5	%

		Percentage of the Company's Total Trade Receivables
Major Accounts		At September 30, 2020				At December 31, 2019
A.S. Watson Group - Related Party			30.6	%			39.0	%
Amazon Marketplaces			15.9	%			10.3	%
Life Extension			15.7	%			27.4	%
Matakana Health			13.4	%		*

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592

+ Details

Name:	us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration